Federal award
BIOMERIEUX INC
W81K0220P0123
Contract
Obligated and Ceiling
- Obligated (net)
- $867,621.50
- Ceiling (potential value, not spending)
- $867,621.50
- Current value
- $867,621.50
- Gross positive obligations
- $867,621.50
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BIOMERIEUX INC · HCNVCMEG9NL6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- COMPAGNIE MERIEUX ALLIANCE · PFPLR7Q9VGC8
- Awarding agency
- Department of War · sub-agency 2100 · office W81K02
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0220P0123
- Award type code
- B
- Actions
- 9 · Jul 28, 2020 to Nov 9, 2022
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Nov 9, 2022 | FY2023 | P00008 | C | $304,080.00 | — |
| Jul 15, 2022 | FY2022 | P00007 | G | $0.00 | — |
| Nov 8, 2021 | FY2022 | P00006 | C | $304,080.00 | — |
| Sep 10, 2021 | FY2021 | P00005 | D | $0.00 | — |
| Jul 13, 2021 | FY2021 | P00004 | B | $8,923.70 | — |
| May 20, 2021 | FY2021 | P00003 | G | $0.00 | — |
| Nov 10, 2020 | FY2021 | P00002 | C | $250,537.80 | — |
| Sep 29, 2020 | FY2020 | P00001 | B | $0.00 | — |
| Jul 28, 2020 | FY2020 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.